SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-029901
Filing Date
2020-10-02
Accepted
2020-10-02 16:02:46
Documents
1
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3638
  Complete submission text file 0001213900-20-029901.txt   5022
Mailing Address 99 BELBROOK WAY ATHERTON CA 94027
Business Address
CASAMENTO CHARLES J (Reporting) CIK: 0001117167 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39082 | Film No.: 201219908

Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations